Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ceftazidime vs Ciprofloxacin for High-Risk Neutropenic Fever in Children
NCT07016165Phase 4Recruiting
- Sponsor
- Universitas Gadjah Mada
- Start
- Jun 2025
- Primary completion
- Nov 2025
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 4 trial of ceftazidime in neutropenic fever, sponsored by Universitas Gadjah Mada. Started Jun 2025; status: recruiting.
02
Drugs
ceftazidime
03
Conditions
neutropenic fever
Beyond the preview
Go deeper on NCT07016165.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07016165.